MEI Pharma CFO Brian Drazba to retire by year-end 2021; search underway

Lite Strategy, Inc.

CFO Brian Drazba to retire effective December 31, 2021; will continue in role until then or until successor appointed.
Drazba entered Transition and Retirement Agreement; receives severance and accelerated vesting of stock options.
Company has initiated search for a new chief financial officer.
Drazba served as CFO since April 2017; contributed to financial infrastructure growth.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brian G. Drazba

Chief Financial Officer and Secretary

LITS · Lite Strategy, Inc.

Effective: 2021-12-31
Filed: August 5, 2021, 7:59 PM ET

On August 2, 2021, Brian G. Drazba, the Chief Financial Officer and Secretary of MEI Pharma, Inc. (the “Company”), and the Company mutually agreed that Mr. Drazba will retire from the Company, effective December 31, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian G. Drazba departed as Chief Financial Officer and Secretary at Lite Strategy, Inc..

Action: retire
Role: Chief Financial Officer and Secretary

Exact text from the filing

On August 2, 2021, Brian G. Drazba, the Chief Financial Officer and Secretary of MEI Pharma, Inc. (the “Company”), and the Company mutually agreed that Mr. Drazba will retire from the Company, effective December 31, 2021.

View on SEC.gov

Lite Strategy, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-237802

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.